<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
        xmlns:content="http://purl.org/rss/1.0/modules/content/"
        xmlns:wfw="http://wellformedweb.org/CommentAPI/"
        xmlns:dc="http://purl.org/dc/elements/1.1/"
        xmlns:atom="http://www.w3.org/2005/Atom"
        xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
        xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
        >
<channel>
        <title>Global Private Equity Watch - Feed</title>
        <atom:link href="https://privateequity.weil.com/category/sell-side/feed/" rel="self" type="application/rss+xml" />
        <link>https://privateequity.weil.com/category/sell-side/</link>
        <description></description>
        <lastBuildDate>Tue, 14 Apr 2026 20:23:07 +0000</lastBuildDate>
        <language></language>
        <sy:updatePeriod>hourly</sy:updatePeriod>
        <sy:updateFrequency>1</sy:updateFrequency>
        
                                        <item>
                        <title>Delaware Declares That Deliberate Fraud Is Indeed Something Completely Different Than Reckless Fraud</title>
                        <link>https://privateequity.weil.com/glenn-west-musings/delaware-declares-that-deliberate-fraud-is-indeed-something-completely-different-than-reckless-fraud/</link>
                        <pubDate>Tue, 16 Mar 2021 14:03:37 +0000</pubDate>
						                                        <dc:creator>
											Glenn D. West</dc:creator>
                                                                <guid isPermaLink="false">http://privateequity.weil.com/?p=7715</guid>
                        <description><![CDATA[By now we should all be well-schooled in the various types and sources of fraud claims, as well as the dangers of undefined fraud...]]></description>
                        <content:encoded><![CDATA[<p>By now we should all be well-schooled in the various types and sources of fraud claims, as well as the dangers of undefined fraud carve-outs to the sell-side in an M&#38;A transaction governed by Delaware law. But a recent decision by the Delaware Supreme Court, Express Scripts, Inc. v. Bracket Holdings Corp., 2021 WL 752744 [&#8230;]</p>
<p>The post <a href="https://privateequity.weil.com/glenn-west-musings/delaware-declares-that-deliberate-fraud-is-indeed-something-completely-different-than-reckless-fraud/">Delaware Declares That Deliberate Fraud Is Indeed Something Completely Different Than Reckless Fraud</a> appeared first on <a href="https://privateequity.weil.com">Global Private Equity Watch</a>.</p>
]]></content:encoded>
                                                                </item>
                                        <item>
                        <title>The Limits of Liability Limitation Provisions: Nonrecourse Clause, Like Exclusive Remedies Provision, May Be Subject to Delaware Public Policy Exception</title>
                        <link>https://privateequity.weil.com/glenn-west-musings/the-limits-of-liability-limitation-provisions/</link>
                        <pubDate>Mon, 25 Jan 2021 16:36:35 +0000</pubDate>
						                                        <dc:creator>
											Glenn D. West</dc:creator>
                                                                <guid isPermaLink="false">http://privateequity.weil.com/?p=7537</guid>
                        <description><![CDATA[There are few things more fundamental to the sell-side private equity deal practice than, to the maximum extent possible...]]></description>
                        <content:encoded><![CDATA[<p>There are few things more fundamental to the sell-side private equity deal practice than, to the maximum extent possible, (1) establishing a contractual cap on post-closing liability for breaches of reps and warranties made by the target company or the selling stockholders and (2) contractually exonerating/releasing the selling entity’s human agents and nonparty affiliates from [&#8230;]</p>
<p>The post <a href="https://privateequity.weil.com/glenn-west-musings/the-limits-of-liability-limitation-provisions/">The Limits of Liability Limitation Provisions: Nonrecourse Clause, Like Exclusive Remedies Provision, May Be Subject to Delaware Public Policy Exception</a> appeared first on <a href="https://privateequity.weil.com">Global Private Equity Watch</a>.</p>
]]></content:encoded>
                                                                </item>
                                        <item>
                        <title>Weil&#8217;s Q3 2016 Quarterly Private Equity Update: Preparing for Exits &#8211; Key Issues for Sponsors Across the U.S., Europe and Asia</title>
                        <link>https://privateequity.weil.com/asia/preparing-exits-key-issues-sponsors-q2-2016/</link>
                        <pubDate>Wed, 09 Nov 2016 17:56:21 +0000</pubDate>
						                                        <dc:creator>
											Christopher R. Machera</dc:creator>
                                                                <guid isPermaLink="false">https://privateequity.weil.com/?p=2008</guid>
                        <description><![CDATA[This issue provides a comparison of some of the interesting trends and issues related to sponsor exits across the U.S., Europe and Asia.]]></description>
                        <content:encoded><![CDATA[<p>Weil’s Global Private Equity Update provides updates on current topics and trends in global private equity. This issue provides a comparison of some of the interesting trends and issues related to sponsor exits across the U.S., Europe and Asia. View Weil&#8217;s Q3 2016 Global Private Equity Update.</p>
<p>The post <a href="https://privateequity.weil.com/asia/preparing-exits-key-issues-sponsors-q2-2016/">Weil&#8217;s Q3 2016 Quarterly Private Equity Update: Preparing for Exits &#8211; Key Issues for Sponsors Across the U.S., Europe and Asia</a> appeared first on <a href="https://privateequity.weil.com">Global Private Equity Watch</a>.</p>
]]></content:encoded>
                                                                </item>
                                        <item>
                        <title>Club Deals Redux</title>
                        <link>https://privateequity.weil.com/features/club-deals-redux/</link>
                        <pubDate>Mon, 31 Oct 2016 13:12:03 +0000</pubDate>
						                                        <dc:creator>
											Christopher R. Machera</dc:creator>
                                                                <guid isPermaLink="false">https://privateequity.weil.com/?p=1994</guid>
                        <description><![CDATA[<p>On the eve of the financial crisis, private equity sponsors were increasingly participating in club deals. Many mega-deals at that time necessitated equity checks in the billions of dollars, and the only way that most private equity sponsors could write those checks was to team up with other sponsors.  The club deal was a hallmark [&#8230;]</p>
<p>The post <a href="https://privateequity.weil.com/features/club-deals-redux/">Club Deals Redux</a> appeared first on <a href="https://privateequity.weil.com">Global Private Equity Watch</a>.</p>
]]></description>
                        <content:encoded><![CDATA[<p>On the eve of the financial crisis, private equity sponsors were increasingly participating in club deals. Many mega-deals at that time necessitated equity checks in the billions of dollars, and the only way that most private equity sponsors could write those checks was to team up with other sponsors.  The club deal was a hallmark [&#8230;]</p>
<p>The post <a href="https://privateequity.weil.com/features/club-deals-redux/">Club Deals Redux</a> appeared first on <a href="https://privateequity.weil.com">Global Private Equity Watch</a>.</p>
]]></content:encoded>
                                                                </item>
                                        <item>
                        <title>Exiting Through an IPO: Key Pre-Investment Considerations</title>
                        <link>https://privateequity.weil.com/ipos/exiting-ipo-key-pre-investment-considerations/</link>
                        <pubDate>Tue, 26 Jul 2016 18:32:10 +0000</pubDate>
						                                        <dc:creator>
											Christopher R. Machera</dc:creator>
                                                                <guid isPermaLink="false">https://privateequity.weil.com/?p=1949</guid>
                        <description><![CDATA[<p>Over the last several years, private equity sponsors have increasingly been looking to the public markets to exit portfolio company investments. Although there is nothing new about sponsors exiting through an initial public offering, stockholders agreements entered into by sponsors at the time of the original investment have not always anticipated properly the various nuances [&#8230;]</p>
<p>The post <a href="https://privateequity.weil.com/ipos/exiting-ipo-key-pre-investment-considerations/">Exiting Through an IPO: Key Pre-Investment Considerations</a> appeared first on <a href="https://privateequity.weil.com">Global Private Equity Watch</a>.</p>
]]></description>
                        <content:encoded><![CDATA[<p>Over the last several years, private equity sponsors have increasingly been looking to the public markets to exit portfolio company investments. Although there is nothing new about sponsors exiting through an initial public offering, stockholders agreements entered into by sponsors at the time of the original investment have not always anticipated properly the various nuances [&#8230;]</p>
<p>The post <a href="https://privateequity.weil.com/ipos/exiting-ipo-key-pre-investment-considerations/">Exiting Through an IPO: Key Pre-Investment Considerations</a> appeared first on <a href="https://privateequity.weil.com">Global Private Equity Watch</a>.</p>
]]></content:encoded>
                                                                </item>
                                        <item>
                        <title>Private Equity Sellers Must View “Fraud Carve-outs” with a Gimlet-Eye</title>
                        <link>https://privateequity.weil.com/features/private-equity-sellers-must-view-fraud-carve-outs-with-a-gimlet-eye/</link>
                        <pubDate>Wed, 16 Mar 2016 13:00:29 +0000</pubDate>
						                                        <dc:creator>
											Glenn D. West</dc:creator>
                                                                <guid isPermaLink="false">https://peblog.wpengine.com/?p=1564</guid>
                        <description><![CDATA[<p>In a March 3, 2016 post to Weil’s Private Equity Insights blog, it was suggested that the means of eliminating the specter of extra-contractual fraud claims is similar to the purported means of neutralizing a fictional zombie; both require a specialized weapon, skillfully wielded to deliver a decisive blow to exactly the right spot.  If [&#8230;]</p>
<p>The post <a href="https://privateequity.weil.com/features/private-equity-sellers-must-view-fraud-carve-outs-with-a-gimlet-eye/">Private Equity Sellers Must View “Fraud Carve-outs” with a Gimlet-Eye</a> appeared first on <a href="https://privateequity.weil.com">Global Private Equity Watch</a>.</p>
]]></description>
                        <content:encoded><![CDATA[<p>In a March 3, 2016 post to Weil’s Private Equity Insights blog, it was suggested that the means of eliminating the specter of extra-contractual fraud claims is similar to the purported means of neutralizing a fictional zombie; both require a specialized weapon, skillfully wielded to deliver a decisive blow to exactly the right spot.  If [&#8230;]</p>
<p>The post <a href="https://privateequity.weil.com/features/private-equity-sellers-must-view-fraud-carve-outs-with-a-gimlet-eye/">Private Equity Sellers Must View “Fraud Carve-outs” with a Gimlet-Eye</a> appeared first on <a href="https://privateequity.weil.com">Global Private Equity Watch</a>.</p>
]]></content:encoded>
                                                                </item>
                                        <item>
                        <title>Exclusive Remedy Provisions, Fraud Carve-outs, and Personal Liability for Sell-Side Private Equity Professionals</title>
                        <link>https://privateequity.weil.com/insights/exclusive-remedy-provisions-fraud-carve-outs-and-personal-liability-for-sell-side-private-equity-professionals/</link>
                        <pubDate>Tue, 01 Dec 2015 22:32:46 +0000</pubDate>
						                                        <dc:creator>
											Glenn D. West</dc:creator>
                                                                <guid isPermaLink="false">https://peblog.wpengine.com/?p=1189</guid>
                        <description><![CDATA[<p>A recent Delaware Court of Chancery decision involving the sale of a business by one private equity firm to another, Prairie Capital III, LP v. Double E Holding Corp., provides another opportunity to remind private equity sellers of the potential for dissatisfied buyers to use fraud claims (even if unfounded) to attempt to gut the [&#8230;]</p>
<p>The post <a href="https://privateequity.weil.com/insights/exclusive-remedy-provisions-fraud-carve-outs-and-personal-liability-for-sell-side-private-equity-professionals/">Exclusive Remedy Provisions, Fraud Carve-outs, and Personal Liability for Sell-Side Private Equity Professionals</a> appeared first on <a href="https://privateequity.weil.com">Global Private Equity Watch</a>.</p>
]]></description>
                        <content:encoded><![CDATA[<p>A recent Delaware Court of Chancery decision involving the sale of a business by one private equity firm to another, Prairie Capital III, LP v. Double E Holding Corp., provides another opportunity to remind private equity sellers of the potential for dissatisfied buyers to use fraud claims (even if unfounded) to attempt to gut the [&#8230;]</p>
<p>The post <a href="https://privateequity.weil.com/insights/exclusive-remedy-provisions-fraud-carve-outs-and-personal-liability-for-sell-side-private-equity-professionals/">Exclusive Remedy Provisions, Fraud Carve-outs, and Personal Liability for Sell-Side Private Equity Professionals</a> appeared first on <a href="https://privateequity.weil.com">Global Private Equity Watch</a>.</p>
]]></content:encoded>
                                                                </item>
                                        <item>
                        <title>R&#038;W Insurance, Part II: Pros and Cons for Sellers</title>
                        <link>https://privateequity.weil.com/insights/rw-insurance-part-ii-pros-cons-sellers/</link>
                        <pubDate>Thu, 28 May 2015 15:15:59 +0000</pubDate>
						                                        <dc:creator>
											Private Equity Alert</dc:creator>
                                                                <guid isPermaLink="false">https://peblog.wpengine.com/?p=789</guid>
                        <description><![CDATA[Weil's Private Equity group discusses R&W Insurance (representations and warranties insurance) from a seller's perspective in private equity transactions.]]></description>
                        <content:encoded><![CDATA[<p>The key advantage of R&#038;W insurance to sellers is limiting (or eliminating) their post-closing liability for breaches of reps and warranties made in the acquisition agreement. </p>
<p>The post <a href="https://privateequity.weil.com/insights/rw-insurance-part-ii-pros-cons-sellers/">R&amp;W Insurance, Part II: Pros and Cons for Sellers</a> appeared first on <a href="https://privateequity.weil.com">Global Private Equity Watch</a>.</p>
]]></content:encoded>
                                                                </item>
        </channel>
</rss>